Blacksburg, VA, United States of America

Andrew Leber

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew Leber

Introduction

Andrew Leber is a prominent inventor based in Blacksburg, Virginia, known for his significant contributions to the field of biopharmaceuticals. With a total of 16 patents to his name, Leber has focused on developing compounds that target critical proteins involved in various diseases. His work has the potential to impact the treatment of numerous inflammatory and metabolic conditions.

Latest Patents

Among his latest patents, Leber has developed compounds targeting the lanthionine synthetase C-like (LANCL) family of proteins, specifically LANCL2 and LANCL3. These compounds are designed to treat a range of conditions, including inflammatory diseases, metabolic diseases, autoimmune diseases, cancers, and infectious diseases. Notable conditions addressed by his inventions include nonalcoholic fatty liver disease, primary biliary cholangitis, Crohn's disease, systemic lupus erythematosus, rheumatoid arthritis, type 1 and type 2 diabetes, psoriasis, and multiple sclerosis. Additionally, he has worked on crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridine-2-yl)methanone), which includes processes for preparing these forms and methods of their use.

Career Highlights

Leber has held key positions in several biopharmaceutical companies, including Landos Biopharma, Inc. and Nimmune Biopharma, Inc. His work in these organizations has been instrumental in advancing research and development in the field of therapeutics.

Collaborations

Throughout his career, Andrew Leber has collaborated with notable professionals such as Josep Bassaganya-Riera and Raquel Hontecillas. These collaborations have contributed to the innovative research and development of new therapeutic solutions.

Conclusion

Andrew Leber's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…